Ralph Lauren Center for Cancer Care and Prevention
7
1
1
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.3%
1 terminated/withdrawn out of 7 trials
83.3%
-3.2% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Role: collaborator
Tobacco-Focused Patient Navigation to Address Barriers to Utilization of Community-Based Smoking Cessation Services in Primary Care
Role: collaborator
Spanish Translation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Role: collaborator
Study of Economic Circumstances, Service Utilization, and Service Needs Among Older Colon Cancer Patients
Role: collaborator
Neuropsychologic and Electrophysiological Features of Cancer-Related Cognitive Side Effects in Racial and Ethnic Minority Breast Cancer Patients
Role: collaborator
An Access Delivery Model That Eliminates Barriers to Breast Cancer Care Delivery
Role: collaborator
Use of Screening Colonoscopy Among Minority Women and Men
Role: collaborator
All 7 trials loaded